Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

A&J Science synthesizes new antibacterials

June 15, 2022

Beijing Jacobio Pharmaceuticals identifies new GTPase KRAS inhibitors

June 15, 2022

Deciphera Pharmaceuticals discloses PERK and/or GCN2 inhibitors

June 15, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Chinese researchers disclose cardiac myosin inhibitors

June 14, 2022

Fochon Pharmaceuticals identifies new BTK inhibitors

June 14, 2022

Qilu Regor Therapeutics presents new STING antagonists

June 14, 2022

Roche discloses new HBV antivirals

June 14, 2022

Beijing Increase Innovation Drug Research divulges SGLT2 inhibitors

June 14, 2022

Roche synthesizes new HBV antivirals

June 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...